These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31971288)

  • 1. Immunosuppression with generic tacrolimus in liver and kidney transplantation-systematic review and meta-analysis on biopsy-proven acute rejection and bioequivalence.
    Kahn J; Pregartner G; Schemmer P
    Transpl Int; 2020 Apr; 33(4):356-372. PubMed ID: 31971288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Once-Daily versus Twice-Daily Tacrolimus in Kidney Transplantation: A Systematic Review and Meta-analysis of Observational Studies.
    Vadcharavivad S; Saengram W; Phupradit A; Poolsup N; Chancharoenthana W
    Drugs; 2019 Dec; 79(18):1947-1962. PubMed ID: 31713065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioequivalence between innovator and generic tacrolimus in liver and kidney transplant recipients: A randomized, crossover clinical trial.
    Alloway RR; Vinks AA; Fukuda T; Mizuno T; King EC; Zou Y; Jiang W; Woodle ES; Tremblay S; Klawitter J; Klawitter J; Christians U
    PLoS Med; 2017 Nov; 14(11):e1002428. PubMed ID: 29135993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generic immunosuppression in solid organ transplantation: systematic review and meta-analysis.
    Molnar AO; Fergusson D; Tsampalieros AK; Bennett A; Fergusson N; Ramsay T; Knoll GA
    BMJ; 2015 Jun; 350():h3163. PubMed ID: 26101226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Transplant Outcomes for Low-level and Standard-level Tacrolimus at Different Time Points after Kidney Transplantation.
    Jung HY; Cho SY; Choi JY; Cho JH; Park SH; Kim YL; Kim HK; Huh S; Won DI; Kim CD
    J Korean Med Sci; 2019 Apr; 34(12):e103. PubMed ID: 30940998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Immunosuppressive Exposure of Enteric-Coated-Mycophenolate Sodium Plus Tacrolimus Associated with Acute Rejection in Expanded Criteria Donor Kidney Transplantation.
    Ding CG; Jiao LZ; Han F; Xiang HL; Tian PX; Ding XM; Pan XM; Tian XH; Li Y; Zheng J; Xue WJ
    Chin Med J (Engl); 2018 Jun; 131(11):1302-1307. PubMed ID: 29786042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generic tacrolimus in solid organ transplantation.
    Taube D; Jones G; O'Beirne J; Wennberg L; Connor A; Rasmussen A; Backman L
    Clin Transplant; 2014 May; 28(5):623-32. PubMed ID: 24750309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppressive therapy for kidney transplantation in adults: a systematic review and economic model.
    Jones-Hughes T; Snowsill T; Haasova M; Coelho H; Crathorne L; Cooper C; Mujica-Mota R; Peters J; Varley-Campbell J; Huxley N; Moore J; Allwood M; Lowe J; Hyde C; Hoyle M; Bond M; Anderson R
    Health Technol Assess; 2016 Aug; 20(62):1-594. PubMed ID: 27578428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended release versus immediate release tacrolimus in kidney transplant recipients: a systematic review and meta-analysis.
    Saengram W; Vadcharavivad S; Poolsup N; Chancharoenthana W
    Eur J Clin Pharmacol; 2018 Oct; 74(10):1249-1260. PubMed ID: 29961086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic review and economic model of the clinical and cost-effectiveness of immunosuppressive therapy for renal transplantation in children.
    Yao G; Albon E; Adi Y; Milford D; Bayliss S; Ready A; Raftery J; Taylor RS
    Health Technol Assess; 2006 Dec; 10(49):iii-iv, ix-xi, 1-157. PubMed ID: 17134597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal everolimus concentration is associated with risk reduction for acute rejection in de novo renal transplant recipients.
    Chan L; Hartmann E; Cibrik D; Cooper M; Shaw LM
    Transplantation; 2010 Jul; 90(1):31-7. PubMed ID: 20517177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized trial with steroids and antithymocyte globulins comparing cyclosporine/azathioprine versus tacrolimus/mycophenolate mofetil (CATM2) in renal transplantation.
    Vacher-Coponat H; Moal V; Indreies M; Purgus R; Loundou A; Burtey S; Brunet P; Moussi-Frances J; Daniel L; Dussol B; Berland Y
    Transplantation; 2012 Feb; 93(4):437-43. PubMed ID: 22228415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppressive therapy for kidney transplantation in children and adolescents: systematic review and economic evaluation.
    Haasova M; Snowsill T; Jones-Hughes T; Crathorne L; Cooper C; Varley-Campbell J; Mujica-Mota R; Coelho H; Huxley N; Lowe J; Dudley J; Marks S; Hyde C; Bond M; Anderson R
    Health Technol Assess; 2016 Aug; 20(61):1-324. PubMed ID: 27557331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo low-dose sirolimus versus mycophenolate mofetil in combination with extended-release tacrolimus in kidney transplant recipients: a multicentre, open-label, randomized, controlled, non-inferiority trial.
    Huh KH; Lee JG; Ha J; Oh CK; Ju MK; Kim CD; Cho HR; Jung CW; Lim BJ; Kim YS;
    Nephrol Dial Transplant; 2017 Aug; 32(8):1415-1424. PubMed ID: 28810721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppression with Generics in Liver and Kidney Transplantation: A Real-World Evidence Study.
    Finocchietti M; Marino ML; Rosa AC; Bellini A; Masiero L; Cardillo M; Massari M; Spila Alegiani S; Pierobon S; Ferroni E; Zanforlini M; Leoni O; Ledda S; Garau D; Davoli M; Addis A; Belleudi V;
    Drug Des Devel Ther; 2024; 18():53-69. PubMed ID: 38229916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo use of generic tacrolimus in liver transplantation - a single center experience with one-yr follow-up.
    Dannhorn E; Cheung M; Rodrigues S; Cooper H; Thorburn D; Patch D; Burroughs AK; O'Beirne J
    Clin Transplant; 2014 Dec; 28(12):1349-57. PubMed ID: 25142496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tacrolimus CYP3A Single-Nucleotide Polymorphisms and Preformed T- and B-Cell Alloimmune Memory Improve Current Pretransplant Rejection-Risk Stratification in Kidney Transplantation.
    Crespo E; Vidal-Alabró A; Jouve T; Fontova P; Stein M; Mocka S; Meneghini M; Sefrin A; Hruba P; Gomà M; Torija A; Donadeu L; Favà A; Cruzado JM; Melilli E; Moreso F; Viklicky O; Bemelman F; Reinke P; Grinyó J; Lloberas N; Bestard O
    Front Immunol; 2022; 13():869554. PubMed ID: 35833145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term Clinical Significance of Tacrolimus Trough Level at the Early Period After Kidney Transplantation.
    Park WY; Paek JH; Jin K; Park SB; Han S
    Transplant Proc; 2019 Oct; 51(8):2643-2647. PubMed ID: 31477420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes in African American kidney transplant patients receiving tacrolimus and mycophenolic acid immunosuppression.
    Narayanan M; Pankewycz O; El-Ghoroury M; Shihab F; Wiland A; McCague K; Chan L
    Transplantation; 2013 Feb; 95(4):566-72. PubMed ID: 23423268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tacrolimus predose concentrations do not predict the risk of acute rejection after renal transplantation: a pooled analysis from three randomized-controlled clinical trials(†).
    Bouamar R; Shuker N; Hesselink DA; Weimar W; Ekberg H; Kaplan B; Bernasconi C; van Gelder T
    Am J Transplant; 2013 May; 13(5):1253-61. PubMed ID: 23480233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.